RFPを含む3方式による肺結核6ヵ月化療の対照試験 (第2報) : 治療終了後1年目の成績
スポンサーリンク
概要
- 論文の詳細を見る
This is an one year follow up study of the cases after completing the 6 months chemothe rapy reported in our 1st report.<BR>The patients were all smear positive with cavity less than 4 cm in diameter or without cavity, and previously untreated or had been treated for less than 15 days.<BR>They were treated with 3 regimens of chemotherapy containing RFP and other companion drugs at the National Nakano Chest Hospital.<BR>A total of 113 cases were allocated to this study but 10 cases were excluded due to the reasons mentioned below.<BR>1) atypical mycobacteria…3 cases, 2) RFP could not be used for longer than 18 days because of side effects…3 cases, 3) death by stomach surgery on the 50th day of chemotherapy…1 case, and 4) retreated elsewhere for 1-3 months after completing the 6 months chemotherapy only due to worry on relapse, although their sputum had been culture negative and without any signs of relapse by that time.3 cases.<BR>The remaining 103 cases were subjected to the follow-up study. One case could not be followed up and 5 cases were followed up only for 1, 4, 7, 8, 10 months after completing 6 months chemotherapy with negative culture until then.<BR>Frequency of sputum examinations of the remaining 97 cases was shown in Table 1.<BR>Three cases relapsed out of 97 cases (Table 2), 2 cases within 6 month and one 9 month after finishing the chemotherapy. In addition one colony of atypical mycobacterium (Runyon Group IV) was found from RHZS group 2 month after completing the chemotherapy, but this case was not retreated and remained negative so far.<BR>Relapsed cases were analysed in relation to the factors before (Table 3) and after treatment (Table 4). But the number was too few to draw any conclusion about the causes of relapse.<BR>The bacilli isolated from these relapsed cases were all sensitive to the used drugs just as before the treatment. Among 3 relapsed cases, 2 were retreated with drugs containing RFP as in-patient and within 2 and 4 months became negative, but the other one who was retreated with RHE as out-patient has not converted until 4 months. As this case had taken the drugs too irregulerly, he was rehospitalized and soon thereafter his sputum converted to negative.<BR>X-ray improvement continued even after stopping 6 months chemotherapy and it suggests that tubercle bacilli in the lesion either died or stopped of the harmful effects to the surrounding tissue. The progress of X-ray improvement until 18 months from the start of chemotherapy was just the same for 6, 12, 18 months chemotherapy groups (Fig. 1).<BR>The same result was seen as to the cavity closure rate in the remaining cavity less than 3 cm in diameter at the end of 6 months chemotherapy. These 12, 18 months groups were the cases treated with RHE from May 1974 to December 1976 in our hospital.
- 日本結核病学会の論文
著者
関連論文
- 外来性再感染によると思われる4症例について-4-総括,討論,結論
- 外来性再感染によると思われる4症例について-3-症例4および症例2,3,4の相互関連その他の検討
- 外来性再感染によると思われる4症例について-2-症例3について
- 外来性再感染によると思われる4症例について-1-症例1および症例2について
- 結核性膿胸患者の治療に関する研究
- 燒灼336名について
- 癌性胸膜炎に対する胸膜生検の診断的意義
- ^Hg : グルタチオンによる肺癌シンチグラフィーの臨床的価値
- 肺癌の放射性第2塩化水銀のマクロオートラジオグラムと組織変化の検討 : 関東支部 : 第39回支部活動
- 11.肺癌における放射性水銀の診断的価値 : 第37回支部会 : 関東支部
- RFPを含む3方式による肺結核6ヵ月化療の対照試験 (第2報) : 治療終了後1年目の成績
- RFPを含む3方式による肺結核6ヵ月化療の対照試験 (第1報)
- 外来性再感染によると思われる4症例について : 第4部総括, 討論, 結論
- 外来性再感染によると思われる4症例について : 第3部 症例4および症例2, 3, 4の相互関連その他の検討
- 外来性再感染によると思われる4症例について : 第2部症例3について
- 外来性再感染によると思われる4症例について : 第1部症例1および症例2について
- 一次薬3者併用におけるSM毎日と週2回の比較 : 特に耐性限界を考慮して (第2報)
- RFPの耐性 (後編)
- RFPの耐性 (前編)
- 次薬3者併用におけるSM毎日と週2回の比較 : ―特に耐性限界を考慮しで(第1報)―
- SM, INH, PASの臨床耐性限界
- 抗結核剤の1回および分服法の比較
- Rifampicinによる肺結核の再治療
- Rifampicinによる肺結核の再治療
- Ethambutolによる視力障害
- D-2,2-(Ethylenediimino)di-1-butanol[Ethambutol, Ebutol]の臨床成績
- D-2, 2-(Ethylenediimino)di-1-butanol[Ethambutol,Ebuto1]の臨床成績
- 糖尿病合併肺結核患者の末梢血白血球によるBCG食菌作用
- エタンブトールの体内分布とその代謝